Your browser doesn't support javascript.
loading
Clinical predictors of bevacizumab-associated intestinal perforation in non-small cell lung cancer.
Tamiya, Motohiro; Suzuki, Hidekazu; Shiroyama, Takayuki; Tanaka, Ayako; Morishita, Naoko; Okamoto, Norio; Sakai, Kenichi; Shigeoka, Hironori; Kawahara, Kunimitsu; Hirashima, Tomonori.
Afiliação
  • Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemachi Chuo-ku, Osaka, 541-8567, Japan. moto19781205@yahoo.co.jp.
  • Suzuki H; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino, Japan.
  • Shiroyama T; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino, Japan.
  • Tanaka A; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino, Japan.
  • Morishita N; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino, Japan.
  • Okamoto N; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino, Japan.
  • Sakai K; Department of Surgery, Osaka Gyoumeikan Hospital, Osaka, Japan.
  • Shigeoka H; Department of Emergency & Critical Care Medicine, Kindai University Faculty of Medicine, Osaka, Japan.
  • Kawahara K; Department of Pathology, Osaka Habikino Medical Center, Habikino, Japan.
  • Hirashima T; Department of Thoracic Malignancy, Osaka Habikino Medical Center, Habikino, Japan.
Invest New Drugs ; 36(4): 696-701, 2018 08.
Article em En | MEDLINE | ID: mdl-29536229

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Bevacizumab / Antineoplásicos Imunológicos / Perfuração Intestinal / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Bevacizumab / Antineoplásicos Imunológicos / Perfuração Intestinal / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão